William Blair analyst Matthew Phipps initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Outperform rating.
Jim Cramer Cut Back On This Tech Giant’s Stock Even Though ‘It Was Painful To Do’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he will hold Cisco Systems Inc (NASDAQ: CSCO) stock in his Charitable Trust.
